Journal of the Korean society of biological therapies in psychiatry (생물치료정신의학)

The Korean Society of Biological Therapies in Psychiatry (대한생물치료정신의학회)
권호 표지

Biological Mechanism of Suicide

자살의 생물학적 기전

  • Cheon, Eun-Jin (Department of Psychiatry, Yeungnam University College of Medicine, Yeungnam University Medical Center)
  • 천은진 (영남대학교 의과대학 정신건강의학교실)
  • Received : 2018.06.30
  • Accepted : 2018.08.23
  • Published : 2018.10.31

⟨ Previous Next ⟩

Abstract

Suicide is a behavior that is intended to cause death by itself and requires medical treatment, resulting in suicidal attempt or completion. Suicide causes loss of life, damages the body, costs a lot of medical expenses, and causes families to fall into sorrow and suffering therefore this suicide is a huge loss to family and society. There have been attempts to reduce and prevent suicide by understanding the mechanism of suicide. The mechanism of suicide can be thought of as psychological mechanism and biological mechanism. In the past, if we considered the psychological and biological mechanisms separately, the development of neuroscience now connects and integrates these two. Psychological factors affect biological factors and biological temperaments also affect perception or thinking about the situation and increase psychological vulnerability. Distant factors in suicidal behavior-such as childhood adversity and family and genetic predisposition-increase the lifetime risk of suicide. They alter the response to stress and other processes through changes in gene expression and regulation of emotional and behavioral characteristics. Distant factors affect the biological system and consequently changes in these systems can increase the risk of suicide. In other words, the distal factor does not directly induce suicidal behavior but rather acts indirectly through developmental or mediating factors. These mediating factors are impulsive aggressive and anxious trait, and chronic use of substances. The mechanism of this disorder is the abnormality of the serotonin system and the abnormality of the lipid level. Proximal factors are associated with the onset of suicide events and include changes in the major neurotransmitter systems, inflammatory changes, and dysfunction of glial cells in the brain. A series of studies, including a variety of research methods and postmortem and in-vivo imaging studies, show the impairment of the serotonergic neurotransmitter system and hypothalamic-pituitary-adrenal axis stress response system for suicidal behavior. These disorders lead to suicidal behavior due to difficulty in cognitive control of mood, pessimism, reactive aggression, abnormality in problem solving abilities, excessive response to negative social signals, severe emotional distress, and cognitive dysregulation of suicidal ideation.

Keywords

References

  1. Turecki G. The molecular bases of the suicidal brain. Nat Rev Neurosci 2014;15:802-16. https://doi.org/10.1038/nrn3839
  2. Turecki G, Brent DA. Suicide and suicidal behaviour. Lancet 2016;387:1227-39. https://doi.org/10.1016/S0140-6736(15)00234-2
  3. Turecki G. Preventing suicide: where are we? Lancet Psychiatry 2016;3:597-8. https://doi.org/10.1016/S2215-0366(16)30068-2
  4. O'Connor RC, Nock MK. The psychology of suicidal behaviour. Lancet Psychiatry 2014;1:73-85. https://doi.org/10.1016/S2215-0366(14)70222-6
  5. Mann JJ. Neurobiology of suicidal behaviour. Nat Rev Neurosci 2003;4:819-28.
  6. Moscicki EK. Gender differences in completed and attempted suicides. Ann Epidemiol 1994;4:152-8. https://doi.org/10.1016/1047-2797(94)90062-0
  7. Van Orden KA, Witte TK, Cukrowicz KC, Braithwaite SR, Selby EA, Joiner TE, Jr, et al. The interpersonal theory of suicide. Psychol Rev 2010;117:575-600. https://doi.org/10.1037/a0018697
  8. Brent DA. Risk factors for adolescent suicide and suicidal behavior: mental and substance abuse disorders, family environmental factors, and life stress. Suicide Life Threat Behav 1995;25 Suppl:52-63. https://doi.org/10.1111/j.1943-278X.1995.tb00490.x
  9. Kim CD, Seguin M, Therrien N, Riopel G, Chawky N, Lesage AD, et al. Familial aggregation of suicidal behavior: a family study of male suicide completers from the general population. Am J Psychiatry 2005;162:1017-9. https://doi.org/10.1176/appi.ajp.162.5.1017
  10. McGirr A, Alda M, Seguin M, Cabot S, Lesage A, Turecki G. Familial aggregation of suicide explained by cluster B traits: a three-group family study of suicide controlling for major depressive disorder. Am J Psychiatry 2009;166:1124-34. https://doi.org/10.1176/appi.ajp.2009.08111744
  11. Tidemalm D, Runeson B, Waern M, Frisell T, Carlstrom E, Lichtenstein P, et al. Familial clustering of suicide risk: a total population study of 11.4 million individuals. Psychol Med 2011;41:2527-34. https://doi.org/10.1017/S0033291711000833
  12. von Borczyskowski A, Lindblad F, Vinnerljung B, Reintjes R, Hjern A. Familial factors and suicide: an adoption study in a Swedish National Cohort. Psychol Med 2011;41:749-58. https://doi.org/10.1017/S0033291710001315
  13. Menke A, Domschke K, Czamara D, Klengel T, Hennings J, Lucae S, et al. Genome-wide association study of antidepressant treatment-emergent suicidal ideation. Neuropsychopharmacology 2012;37:797-807. https://doi.org/10.1038/npp.2011.257
  14. Perlis RH, Huang J, Purcell S, Fava M, Rush AJ, Sullivan PF, et al. Genome-wide association study of suicide attempts in mood disorder patients. Am J Psychiatry 2010;167:1499-507. https://doi.org/10.1176/appi.ajp.2010.10040541
  15. Galfalvy H, Zalsman G, Huang YY, Murphy L, Rosoklija G, Dwork AJ, et al. A pilot genome wide association and gene expression array study of suicide with and without major depression. World J Biol Psychiatry 2013;14:574-82. https://doi.org/10.3109/15622975.2011.597875
  16. Perroud N, Uher R, Ng MY, Guipponi M, Hauser J, Henigsberg N, et al. Genome-wide association study of increasing suicidal ideation during antidepressant treatment in the GENDEP project. Pharmacogenomics J 2012;12:68-77. https://doi.org/10.1038/tpj.2010.70
  17. Willour VL, Seifuddin F, Mahon PB, Jancic D, Pirooznia M, Steele J, et al. A genome-wide association study of attempted suicide. Mol Psychiatry 2012;17:433-44. https://doi.org/10.1038/mp.2011.4
  18. Perlis RH, Ruderfer D, Hamilton SP, Ernst C. Copy number variation in subjects with major depressive disorder who attempted suicide. PLoS One 2012;7:e46315. https://doi.org/10.1371/journal.pone.0046315
  19. Gilbert R, Widom CS, Browne K, Fergusson D, Webb E, Janson S. Burden and consequences of child maltreatment in high-income countries. Lancet 2009;373:68-81. https://doi.org/10.1016/S0140-6736(08)61706-7
  20. Fanous AH, Prescott CA, Kendler KS. The prediction of thoughts of death or self-harm in a population-based sample of female twins. Psychol Med 2004;34:301-12. https://doi.org/10.1017/S0033291703008857
  21. Brezo J, Paris J, Barker ED, Tremblay R, Vitaro F, Zoccolillo M, et al. Natural history of suicidal behaviors in a population-based sample of young adults. Psychol Med 2007;37:1563-74. https://doi.org/10.1017/S003329170700058X
  22. Lopez-Castroman J, Melhem N, Birmaher B, Greenhill L, Kolko D, Stanley B, et al. Early childhood sexual abuse increases suicidal intent. World Psychiatry 2013;12:149-54. https://doi.org/10.1002/wps.20039
  23. Brezo J, Paris J, Vitaro F, Hebert M, Tremblay RE, Turecki G. Predicting suicide attempts in young adults with histories of childhood abuse. Br J Psychiatry 2008;193:134-9. https://doi.org/10.1192/bjp.bp.107.037994
  24. Fergusson DM, Woodward LJ, Horwood LJ. Risk factors and life processes associated with the onset of suicidal behaviour during adolescence and early adulthood. Psychol Med 2000;30:23-39. https://doi.org/10.1017/S003329179900135X
  25. Angst J, Degonda M, Ernst C. The Zurich Study: XV. Suicide attempts in a cohort from age 20 to 30. Eur Arch Psychiatry Clin Neurosci 1992;242:135-41. https://doi.org/10.1007/BF02191561
  26. Hertzman C. Putting the concept of biological embedding in historical perspective. Proc Natl Acad Sci U S A 2012;109 Suppl 2:17160-7. https://doi.org/10.1073/pnas.1202203109
  27. Heim C, Shugart M, Craighead WE, Nemeroff CB. Neurobiological and psychiatric consequences of child abuse and neglect. Dev Psychobiol 2010;52:671-90. https://doi.org/10.1002/dev.20494
  28. McGowan PO, Sasaki A, D'Alessio AC, Dymov S, Labonte B, Szyf M, et al. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci 2009;12:342-8. https://doi.org/10.1038/nn.2270
  29. Binder EB, Bradley RG, Liu W, Epstein MP, Deveau TC, Mercer KB, et al. Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA 2008;299:1291-305. https://doi.org/10.1001/jama.299.11.1291
  30. Supriyanto I, Sasada T, Fukutake M, Asano M, Ueno Y, Nagasaki Y, et al. Association of FKBP5 gene haplotypes with completed suicide in the Japanese population. Prog Neuropsychopharmacol Biol Psychiatry 2011;35:252-6. https://doi.org/10.1016/j.pnpbp.2010.11.019
  31. Labonte B, Suderman M, Maussion G, Lopez JP, Navarro-Sanchez L, Yerko V, et al. Genome-wide methylation changes in the brains of suicide completers. Am J Psychiatry 2013;170:511-20. https://doi.org/10.1176/appi.ajp.2012.12050627
  32. Weder N, Zhang H, Jensen K, Yang BZ, Simen A, Jackowski A, et al. Child abuse, depression, and methylation in genes involved with stress, neural plasticity, and brain circuitry. J Am Acad Child Adolesc Psychiatry 2014;53:417-24 e5. https://doi.org/10.1016/j.jaac.2013.12.025
  33. Roth TL, Lubin FD, Funk AJ, Sweatt JD. Lasting epigenetic influence of early-life adversity on the BDNF gene. Biol Psychiatry 2009;65:760-9. https://doi.org/10.1016/j.biopsych.2008.11.028
  34. Roth TL, Zoladz PR, Sweatt JD, Diamond DM. Epigenetic modification of hippocampal Bdnf DNA in adult rats in an animal model of post-traumatic stress disorder. J Psychiatr Res 2011;45:919-26. https://doi.org/10.1016/j.jpsychires.2011.01.013
  35. Dwivedi Y, Rizavi HS, Conley RR, Roberts RC, Tamminga CA, Pandey GN. Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry 2003;60:804-15. https://doi.org/10.1001/archpsyc.60.8.804
  36. Pandey GN, Ren X, Rizavi HS, Conley RR, Roberts RC, Dwivedi Y. Brain-derived neurotrophic factor and tyrosine kinase B receptor signalling in post-mortem brain of teenage suicide victims. Int J Neuropsychopharmacol 2008;11:1047-61. https://doi.org/10.1017/S1461145708009000
  37. Ernst C, Deleva V, Deng X, Sequeira A, Pomarenski A, Klempan T, et al. Alternative splicing, methylation state, and expression profile of tropomyosin-related kinase B in the frontal cortex of suicide completers. Arch Gen Psychiatry 2009;66:22-32. https://doi.org/10.1001/archpsyc.66.1.22
  38. Keller S, Sarchiapone M, Zarrilli F, Videtic A, Ferraro A, Carli V, et al. Increased BDNF promoter methylation in the Wernicke area of suicide subjects. Arch Gen Psychiatry 2010;67:258-67. https://doi.org/10.1001/archgenpsychiatry.2010.9
  39. Banerjee R, Ghosh AK, Ghosh B, Bhattacharyya S, Mondal AC. Decreased mRNA and Protein Expression of BDNF, NGF, and their Receptors in the Hippocampus from Suicide: An Analysis in Human Postmortem Brain. Clin Med Insights Pathol 2013;6:1-11.
  40. Fuchikami M, Morinobu S, Segawa M, Okamoto Y, Yamawaki S, Ozaki N, et al. DNA methylation profiles of the brain-derived neurotrophic factor(BDNF) gene as a potent diagnostic biomarker in major depression. PLoS One 2011;6:e23881. https://doi.org/10.1371/journal.pone.0023881
  41. Kim JM, Kang HJ, Bae KY, Kim SW, Shin IS, Kim HR, et al. Association of BDNF promoter methylation and genotype with suicidal ideation in elderly Koreans. Am J Geriatr Psychiatry 2014;22:989-96. https://doi.org/10.1016/j.jagp.2014.02.011
  42. Zhang X, Yazaki J, Sundaresan A, Cokus S, Chan SW, Chen H, et al. Genome-wide high-resolution mapping and functional analysis of DNA methylation in arabidopsis. Cell 2006;126:1189-201. https://doi.org/10.1016/j.cell.2006.08.003
  43. Ziller MJ, Gu H, Muller F, Donaghey J, Tsai LT, Kohlbacher O, et al. Charting a dynamic DNA methylation landscape of the human genome. Nature 2013;500:477-81. https://doi.org/10.1038/nature12433
  44. Schroeder M, Hillemacher T, Bleich S, Frieling H. The epigenetic code in depression: implications for treatment. Clinical Pharmacology & Therapeutics 2012;91: 310-4. https://doi.org/10.1038/clpt.2011.282
  45. Turecki G, Ota VK, Belangero SI, Jackowski A, Kaufman J. Early life adversity, genomic plasticity, and psychopathology. Lancet Psychiatry 2014;1:461-6. https://doi.org/10.1016/S2215-0366(14)00022-4
  46. Brent DA, Bridge J, Johnson BA, Connolly J. Suicidal behavior runs in families. A controlled family study of adolescent suicide victims. Arch Gen Psychiatry 1996;53:1145-52. https://doi.org/10.1001/archpsyc.1996.01830120085015
  47. Courtet P, Gottesman, II, Jollant F, Gould TD. The neuroscience of suicidal behaviors: what can we expect from endophenotype strategies? Transl Psychiatry 2011;1.
  48. Brezo J, Barker ED, Paris J, Hebert M, Vitaro F, Tremblay RE, et al. Childhood trajectories of anxiousness and disruptiveness as predictors of suicide attempts. Arch Pediatr Adolesc Med 2008;162:1015-21. https://doi.org/10.1001/archpedi.162.11.1015
  49. Dumais A, Lesage AD, Alda M, Rouleau G, Dumont M, Chawky N, et al. Risk factors for suicide completion in major depression: a case-control study of impulsive and aggressive behaviors in men. Am J Psychiatry 2005;162:2116-24. https://doi.org/10.1176/appi.ajp.162.11.2116
  50. Arsenault-Lapierre G, Kim C, Turecki G. Psychiatric diagnoses in 3275 suicides: a meta-analysis. BMC Psychiatry 2004;4:37. https://doi.org/10.1186/1471-244X-4-37
  51. Rucker JJ, Breen G, Pinto D, Pedroso I, Lewis CM, Cohen-Woods S, et al. Genome-wide association analysis of copy number variation in recurrent depressive disorder. Mol Psychiatry 2013;18:183-9. https://doi.org/10.1038/mp.2011.144
  52. Kim C, Lesage A, Seguin M, Chawky N, Vanier C, Lipp O, et al. Patterns of co-morbidity in male suicide completers. Psychol Med 2003;33:1299-309. https://doi.org/10.1017/S0033291703008146
  53. Seguin M, Lesage A, Turecki G, Bouchard M, Chawky N, Tremblay N, et al. Life trajectories and burden of adversity: mapping the developmental profiles of suicide mortality. Psychol Med 2007;37:1575-83. https://doi.org/10.1017/S0033291707000955
  54. Chachamovich E, Ding Y, Turecki G. Levels of aggressiveness are higher among alcohol-related suicides: results from a psychological autopsy study. Alcohol 2012;46:529-36. https://doi.org/10.1016/j.alcohol.2012.03.007
  55. Coccaro EF, Siever LJ, Klar HM, Maurer G, Cochrane K, Cooper TB, et al. Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior. Arch Gen Psychiatry 1989;46:587-99. https://doi.org/10.1001/archpsyc.1989.01810070013002
  56. Freemantle E, Chen GG, Cruceanu C, Mechawar N, Turecki G. Analysis of oxysterols and cholesterol in prefrontal cortex of suicides. Int J Neuropsychopharmacol 2013;16:1241-9. https://doi.org/10.1017/S1461145712001587
  57. Lalovic A, Levy E, Luheshi G, Canetti L, Grenier E, Sequeira A, et al. Cholesterol content in brains of suicide completers. Int J Neuropsychopharmacol 2007;10:159-66. https://doi.org/10.1017/S1461145706006663
  58. Ernst C, Mechawar N, Turecki G. Suicide neurobiology. Prog Neurobiol 2009;89:315-33. https://doi.org/10.1016/j.pneurobio.2009.09.001
  59. Qin P, Agerbo E, Mortensen PB. Suicide risk in relation to family history of completed suicide and psychiatric disorders: a nested case-control study based on longitudinal registers. Lancet 2002;360:1126-30. https://doi.org/10.1016/S0140-6736(02)11197-4
  60. Asberg M, Thoren P, Traskman L, Bertilsson L, Ringberger V. "Serotonin depression"--a biochemical subgroup within the affective disorders? Science 1976;191:478-80.
  61. Stanley M, Virgilio J, Gershon S. Tritiated imipramine binding sites are decreased in the frontal cortex of suicides. Science 1982;216:1337-9. https://doi.org/10.1126/science.7079769
  62. Stanley M, Mann JJ. Increased serotonin-2 binding sites in frontal cortex of suicide victims. Lancet 1983;1:214-6.
  63. Mann JJ. The serotonergic system in mood disorders and suicidal behaviour. Philos Trans R Soc Lond B Biol Sci 2013;368:20120537. https://doi.org/10.1098/rstb.2012.0537
  64. Parsey RV, Oquendo MA, Ogden RT, Olvet DM, Simpson N, Huang YY, et al. Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study. Biol Psychiatry 2006;59:106-13. https://doi.org/10.1016/j.biopsych.2005.06.016
  65. Arango V, Underwood MD, Boldrini M, Tamir H, Kassir SA, Hsiung S, et al. Serotonin 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims. Neuropsychopharmacology 2001;25:892-903. https://doi.org/10.1016/S0893-133X(01)00310-4
  66. Miller JM, Hesselgrave N, Ogden RT, Sullivan GM, Oquendo MA, Mann JJ, et al. Positron emission tomography quantification of serotonin transporter in suicide attempters with major depressive disorder. Biol Psychiatry 2013;74:287-95. https://doi.org/10.1016/j.biopsych.2013.01.024
  67. Yanowitch R, Coccaro EF. The neurochemistry of human aggression. Adv Genet 2011;75:151-69.
  68. Brezo J, Bureau A, Merette C, Jomphe V, Barker ED, Vitaro F, et al. Differences and similarities in the serotonergic diathesis for suicide attempts and mood disorders: a 22-year longitudinal gene-environment study. Mol Psychiatry 2010;15:831-43. https://doi.org/10.1038/mp.2009.19
  69. Smith KA, Fairburn CG, Cowen PJ. Relapse of depression after rapid depletion of tryptophan. Lancet 1997;349:915-9. https://doi.org/10.1016/S0140-6736(96)07044-4
  70. Benkelfat C, Ellenbogen MA, Dean P, Palmour RM, Young SN. Mood-lowering effect of tryptophan depletion. Enhanced susceptibility in young men at genetic risk for major affective disorders. Arch Gen Psychiatry 1994;51:687-97. https://doi.org/10.1001/archpsyc.1994.03950090019003
  71. Arango V, Underwood MD, Mann JJ. Fewer pigmented locus coeruleus neurons in suicide victims: preliminary results. Biol Psychiatry 1996;39:112-20. https://doi.org/10.1016/0006-3223(95)00107-7
  72. Galfalvy H, Currier D, Oquendo MA, Sullivan G, Huang YY, John Mann J. Lower CSF MHPG predicts short-term risk for suicide attempt. Int J Neuropsychopharmacol 2009;12:1327-35. https://doi.org/10.1017/S1461145709990228
  73. van Heeringen K, Mann JJ. The neurobiology of suicide. Lancet Psychiatry 2014;1:63-72. https://doi.org/10.1016/S2215-0366(14)70220-2
  74. Choudary PV, Molnar M, Evans SJ, Tomita H, Li JZ, Vawter MP, et al. Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc Natl Acad Sci U S A 2005;102:15653-8. https://doi.org/10.1073/pnas.0507901102
  75. Sequeira A, Mamdani F, Ernst C, Vawter MP, Bunney WE, Lebel V, et al. Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression. PLoS One 2009;4:e6585. https://doi.org/10.1371/journal.pone.0006585
  76. Larkin GL, Beautrais AL. A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department. Int J Neuropsychopharmacol 2011;14:1127-31. https://doi.org/10.1017/S1461145711000629
  77. Price RB, Iosifescu DV, Murrough JW, Chang LC, Al Jurdi RK, Iqbal SZ, et al. Effects of ketamine on explicit and implicit suicidal cognition: a randomized controlled trial in treatment-resistant depression. Depress Anxiety 2014;31:335-43. https://doi.org/10.1002/da.22253
  78. Gilad GM, Gilad VH. Overview of the brain polyaminestress-response: regulation, development, and modulation by lithium and role in cell survival. Cell Mol Neurobiol 2003;23:637-49. https://doi.org/10.1023/A:1025036532672
  79. Hayashi Y, Tanaka J, Morizumi Y, Kitamura Y, Hattori Y. Polyamine levels in brain and plasma after acute restraint or water-immersion restraint stress in mice. Neurosci Lett 2004;355:57-60. https://doi.org/10.1016/j.neulet.2003.10.027
  80. Doyle KM, Kirby BP, Murphy D, Shaw GG. Effect of Ltype calcium channel antagonists on spermine-induced CNS excitation in vivo. Neurosci Lett 2005;380:247-51. https://doi.org/10.1016/j.neulet.2005.01.052
  81. Sequeira A, Gwadry FG, Ffrench-Mullen JM, Canetti L, Gingras Y, Casero RA, Jr, et al. Implication of SSAT by gene expression and genetic variation in suicide and major depression. Arch Gen Psychiatry 2006;63:35-48. https://doi.org/10.1001/archpsyc.63.1.35
  82. Fiori LM, Bureau A, Labbe A, Croteau J, Noel S, Merette C, et al. Global gene expression profiling of the polyamine system in suicide completers. Int J Neuropsychopharmacol 2011;14:595-605. https://doi.org/10.1017/S1461145710001574
  83. Klempan TA, Rujescu D, Merette C, Himmelman C, Sequeira A, Canetti L, et al. Profiling brain expression of the spermidine/spermine N1-acetyltransferase 1(SAT1) gene in suicide. Am J Med Genet B Neuropsychiatr Genet 2009;150B:934-43. https://doi.org/10.1002/ajmg.b.30920
  84. Chen GG, Fiori LM, Moquin L, Gratton A, Mamer O, Mechawar N, et al. Evidence of altered polyamine concentrations in cerebral cortex of suicide completers. Neuropsychopharmacology 2010;35:1477-84. https://doi.org/10.1038/npp.2010.17
  85. Guipponi M, Deutsch S, Kohler K, Perroud N, Le Gal F, Vessaz M, et al. Genetic and epigenetic analysis of SSAT gene dysregulation in suicidal behavior. Am J Med Genet B Neuropsychiatr Genet 2009;150B:799-807. https://doi.org/10.1002/ajmg.b.30901
  86. Le-Niculescu H, Levey DF, Ayalew M, Palmer L, Gavrin LM, Jain N, et al. Discovery and validation of blood biomarkers for suicidality. Mol Psychiatry 2013;18:1249-64. https://doi.org/10.1038/mp.2013.95
  87. Dahel KA, Al-Saffar NM, Flayeh KA. Polyamine oxidase activity in sera of depressed and schizophrenic patients after ECT treatment. Neurochem Res 2001;26:415-8. https://doi.org/10.1023/A:1010959300545
  88. Engelberg H. Low serum cholesterol and suicide. Lancet 1992;339:727-9. https://doi.org/10.1016/0140-6736(92)90609-7
  89. Wu S, Ding Y, Wu F, Xie G, Hou J, Mao P. Serum lipid levels and suicidality: a meta-analysis of 65 epidemiological studies. J Psychiatry Neurosci 2016;41:56-69. https://doi.org/10.1503/jpn.150079
  90. De Berardis D, Marini S, Piersanti M, Cavuto M, Perna G, Valchera A, et al. The Relationships between Cholesterol and Suicide: An Update. ISRN Psychiatry 2012;2012:387901.
  91. Serafini G, Pompili M, Elena Seretti M, Stefani H, Palermo M, Coryell W, et al. The role of inflammatory cytokines in suicidal behavior: a systematic review. Eur Neuropsychopharmacol 2013;23:1672-86. https://doi.org/10.1016/j.euroneuro.2013.06.002
  92. Isung J, Aeinehband S, Mobarrez F, Martensson B, Nordstrom P, Asberg M, et al. Low vascular endothelial growth factor and interleukin-8 in cerebrospinal fluid of suicide attempters. Transl Psychiatry 2012;2:e196. https://doi.org/10.1038/tp.2012.123
  93. Erhardt S, Lim CK, Linderholm KR, Janelidze S, Lindqvist D, Samuelsson M, et al. Connecting inflammation with glutamate agonism in suicidality. Neuropsychopharmacology 2013;38:743-52. https://doi.org/10.1038/npp.2012.248
  94. Sublette ME, Galfalvy HC, Fuchs D, Lapidus M, Grunebaum MF, Oquendo MA, et al. Plasma kynurenine levels are elevated in suicide attempters with major depressive disorder. Brain Behav Immun 2011;25:1272-8. https://doi.org/10.1016/j.bbi.2011.05.002
  95. Carlborg A, Jokinen J, Jonsson EG, Erhardt S, Nordstrom P. CSF kynurenic acid and suicide risk in schizophrenia spectrum psychosis. Psychiatry Res 2013;205:165-7. https://doi.org/10.1016/j.psychres.2012.08.021
  96. Bay-Richter C, Linderholm KR, Lim CK, Samuelsson M, Traskman-Bendz L, Guillemin GJ, et al. A role for inflammatory metabolites as modulators of the glutamate N-methyl-D-aspartate receptor in depression and suicidality. Brain Behav Immun 2015;43:110-7. https://doi.org/10.1016/j.bbi.2014.07.012
  97. Pandey GN, Rizavi HS, Ren X, Fareed J, Hoppensteadt DA, Roberts RC, et al. Proinflammatory cytokines in the prefrontal cortex of teenage suicide victims. J Psychiatr Res 2012;46:57-63. https://doi.org/10.1016/j.jpsychires.2011.08.006
  98. Tonelli LH, Stiller J, Rujescu D, Giegling I, Schneider B, Maurer K, et al. Elevated cytokine expression in the orbitofrontal cortex of victims of suicide. Acta Psychiatr Scand 2008;117:198-206. https://doi.org/10.1111/j.1600-0447.2007.01128.x
  99. Torres-Platas SG, Cruceanu C, Chen GG, Turecki G, Mechawar N. Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulate white matter of depressed suicides. Brain Behav Immun 2014;42:50-9. https://doi.org/10.1016/j.bbi.2014.05.007
  100. Steiner J, Bielau H, Brisch R, Danos P, Ullrich O, Mawrin C, et al. Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. J Psychiatr Res 2008;42:151-7. https://doi.org/10.1016/j.jpsychires.2006.10.013
  101. Ehlert U. Enduring psychobiological effects of childhood adversity. Psychoneuroendocrinology 2013;38:1850-7. https://doi.org/10.1016/j.psyneuen.2013.06.007
  102. Danese A, Moffitt TE, Pariante CM, Ambler A, Poulton R, Caspi A. Elevated inflammation levels in depressed adults with a history of childhood maltreatment. Arch Gen Psychiatry 2008;65:409-15. https://doi.org/10.1001/archpsyc.65.4.409
  103. Rajkowska G. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol Psychiatry 2000;48:766-77. https://doi.org/10.1016/S0006-3223(00)00950-1
  104. Torres-Platas SG, Hercher C, Davoli MA, Maussion G, Labonte B, Turecki G, et al. Astrocytic hypertrophy in anterior cingulate white matter of depressed suicides. Neuropsychopharmacology 2011;36:2650-8. https://doi.org/10.1038/npp.2011.154
  105. Ernst C, Nagy C, Kim S, Yang JP, Deng X, Hellstrom IC, et al. Dysfunction of astrocyte connexins 30 and 43 in dorsal lateral prefrontal cortex of suicide completers. Biol Psychiatry 2011;70:312-9. https://doi.org/10.1016/j.biopsych.2011.03.038
  106. Bernard R, Kerman IA, Thompson RC, Jones EG, Bunney WE, Barchas JD, et al. Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression. Mol Psychiatry 2011;16:634-46. https://doi.org/10.1038/mp.2010.44
  107. Rose CR, Blum R, Pichler B, Lepier A, Kafitz KW, Konnerth A. Truncated TrkB-T1 mediates neurotrophin-evoked calcium signalling in glia cells. Nature 2003;426:74-8. https://doi.org/10.1038/nature01983
  108. Razzoli M, Domenici E, Carboni L, Rantamaki T, Lindholm J, Castren E, et al. A role for BDNF/TrkB signaling in behavioral and physiological consequences of social defeat stress. Genes Brain Behav 2011;10:424-33. https://doi.org/10.1111/j.1601-183X.2011.00681.x
  109. Roy A. Hypothalamic-pituitary-adrenal axis function and suicidal behavior in depression. Biol Psychiatry 1992;32:812-6. https://doi.org/10.1016/0006-3223(92)90084-D
  110. Coryell W, Schlesser M. The dexamethasone suppression test and suicide prediction. Am J Psychiatry 2001;158:748-53. https://doi.org/10.1176/appi.ajp.158.5.748
  111. Pfeffer CR, Stokes P, Shindledecker R. Suicidal behavior and hypothalamic-pituitary-adrenocortical axis indices in child psychiatric inpatients. Biol Psychiatry 1991;29:909-17. https://doi.org/10.1016/0006-3223(91)90057-S
  112. Raadsheer FC, van Heerikhuize JJ, Lucassen PJ, Hoogendijk WJ, Tilders FJ, Swaab DF. Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. Am J Psychiatry 1995;152:1372-6. https://doi.org/10.1176/ajp.152.9.1372
  113. Raadsheer FC, Hoogendijk WJ, Stam FC, Tilders FJ, Swaab DF. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology 1994;60:436-44. https://doi.org/10.1159/000126778
  114. Wang SS, Kamphuis W, Huitinga I, Zhou JN, Swaab DF. Gene expression analysis in the human hypothalamus in depression by laser microdissection and realtime PCR: the presence of multiple receptor imbalances. Mol Psychiatry 2008;13:786-99, 41. https://doi.org/10.1038/mp.2008.38
  115. Nemeroff CB, Widerlov E, Bissette G, Walleus H, Karlsson I, Eklund K, et al. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 1984;226:1342-4. https://doi.org/10.1126/science.6334362
  116. Nemeroff CB, Owens MJ, Bissette G, Andorn AC, Stanley M. Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims. Arch Gen Psychiatry 1988;45:577-9. https://doi.org/10.1001/archpsyc.1988.01800300075009
  117. Lopez JF, Palkovits M, Arato M, Mansour A, Akil H, Watson SJ. Localization and quantification of proopiomelanocortin mRNA and glucocorticoid receptor mRNA in pituitaries of suicide victims. Neuroendocrinology 1992;56:491-501. https://doi.org/10.1159/000126266
  118. Dumser T, Barocka A, Schubert E. Weight of adrenal glands may be increased in persons who commit suicide. Am J Forensic Med Pathol 1998;19:72-6. https://doi.org/10.1097/00000433-199803000-00014
  119. Szigethy E, Conwell Y, Forbes NT, Cox C, Caine ED. Adrenal weight and morphology in victims of completed suicide. Biol Psychiatry 1994;36:374-80. https://doi.org/10.1016/0006-3223(94)91212-2
  120. McGirr A, Diaconu G, Berlim MT, Pruessner JC, Sable R, Cabot S, et al. Dysregulation of the sympathetic nervous system, hypothalamic-pituitary-adrenal axis and executive function in individuals at risk for suicide. J Psychiatry Neurosci 2010;35:399-408. https://doi.org/10.1503/jpn.090121
  121. Oquendo MA, Placidi GP, Malone KM, Campbell C, Keilp J, Brodsky B, et al. Positron emission tomography of regional brain metabolic responses to a serotonergic challenge and lethality of suicide attempts in major depression. Arch Gen Psychiatry 2003;60:14-22. https://doi.org/10.1001/archpsyc.60.1.14
  122. Leyton M, Paquette V, Gravel P, Rosa-Neto P, Weston F, Diksic M, et al. alpha-[11C]Methyl-L-tryptophan trapping in the orbital and ventral medial prefrontal cortex of suicide attempters. Eur Neuropsychopharmacol 2006;16:220-3. https://doi.org/10.1016/j.euroneuro.2005.09.006
  123. van Heeringen K, Van den Abbeele D, Vervaet M, Soenen L, Audenaert K. The functional neuroanatomy of mental pain in depression. Psychiatry Res 2010;181:141-4. https://doi.org/10.1016/j.pscychresns.2009.07.011
  124. Oquendo MA, Galfalvy H, Sullivan GM, Miller JM, Milak MM, Sublette ME, et al. Positron Emission Tomographic Imaging of the Serotonergic System and Prediction of Risk and Lethality of Future Suicidal Behavior. JAMA Psychiatry 2016;73:1048-55. https://doi.org/10.1001/jamapsychiatry.2016.1478
  125. van Heeringen C, Bijttebier S, Godfrin K. Suicidal brains: a review of functional and structural brain studies in association with suicidal behaviour. Neurosci Biobehav Rev 2011;35:688-98. https://doi.org/10.1016/j.neubiorev.2010.08.007
  126. Tanaka SC, Doya K, Okada G, Ueda K, Okamoto Y, Yamawaki S. Prediction of immediate and future rewards differentially recruits cortico-basal ganglia loops. Nat Neurosci 2004;7:887-93. https://doi.org/10.1038/nn1279
  127. Richard-Devantoy S, Berlim MT, Jollant F. A metaanalysis of neuropsychological markers of vulnerability to suicidal behavior in mood disorders. Psychol Med 2014;44:1663-73. https://doi.org/10.1017/S0033291713002304
  128. Jollant F, Lawrence NS, Giampietro V, Brammer MJ, Fullana MA, Drapier D, et al. Orbitofrontal cortex response to angry faces in men with histories of suicide attempts. Am J Psychiatry 2008;165:740-8. https://doi.org/10.1176/appi.ajp.2008.07081239
  129. Pan L, Segreti A, Almeida J, Jollant F, Lawrence N, Brent D, et al. Preserved hippocampal function during learning in the context of risk in adolescent suicide attempt. Psychiatry Res 2013;211:112-8. https://doi.org/10.1016/j.pscychresns.2012.07.008
  130. Willeumier K, Taylor DV, Amen DG. Decreased cerebral blood flow in the limbic and prefrontal cortex using SPECT imaging in a cohort of completed suicides. Transl Psychiatry 2011;1:e28. https://doi.org/10.1038/tp.2011.28
  131. Jollant F, Lawrence NS, Olie E, O'Daly O, Malafosse A, Courtet P, et al. Decreased activation of lateral orbitofrontal cortex during risky choices under uncertainty is associated with disadvantageous decision-making and suicidal behavior. Neuroimage 2010;51:1275-81. https://doi.org/10.1016/j.neuroimage.2010.03.027
  132. Pan LA, Batezati-Alves SC, Almeida JR, Segreti A, Akkal D, Hassel S, et al. Dissociable patterns of neural activity during response inhibition in depressed adolescents with and without suicidal behavior. J Am Acad Child Adolesc Psychiatry 2011;50:602-11e3. https://doi.org/10.1016/j.jaac.2011.03.018